Intermedeol Isolated from the Leaves of Ligularia fischeri var. spiciformis Induces the Differentiation of Human Acute Promyeocytic Leukemia HL-60 Cells

Abstract

The present work was performed to investigate the effects of intermedeol on proliferation and differentiation of human leukemia-derived HL-60 cells as well as the underlying mechanisms for these effects. Intermedeol exhibited a potent antiproliferative activity against HL-60 cells. In addition, this compound was found to be a potent inducer for HL-60 cell differentiation as assessed by nitroblue tetrazolium reduction test, esterase activity assay, phagocytic activity assay, morphology change, and expression of CD14 and CD66b surface antigens. These results suggest that intermedeol induces differentiation of human leukemia cells to granulocytes and monocytes/macrophage lineage. Moreover, the expression level of c-myc was down-regulated during intermedeol-dependent HL-60 cell differentiation, whereas p21^CIP1 was up-regulated. Taken together, our results suggest that intermedeol may have potential as a therapeutic agent in human leukemia.

Key words

Ligularia fischeri var. spiciformis - Compositae - intermedeol - differentiation - CD14 - CD66b - c-myc - p21^CIP1 - HL-60 cells

References

• 1 Hong W K, Sporn M B. Recent advances in chemoprevention of cancer.  Science. 1997;  278 1073-7
• 2 Suh N, Luyengi L, Fong H H, Kinghorn A D, Pezzuto J M. Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model.  Anticancer Res.. 1995;  15 233-9
• 3 Collins S J, Ruscetti F W, Gallagher R E, Gallo R C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl. Acad. Sci.  U S A.. 1978;  75 2458-62
• 4 Yam L T, Li C Y, Crosby W H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin.  Pathol.. 1971;  55 283-90
• 5 Harris P E, Ralph P, Gabrilove J, Welte K, Karmali R, Moore M A. Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60.  Cancer Res.. 1985;  45 3090-5
• 6 Honma Y, Takenaga K, Kasukabe T, Hozumi M. Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem. Biophys. Res.  Commun.. 1980;  95 507-12
• 7 Koeffler H P, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca H F. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D₃ and its fluorinated analogues.  Cancer Res.. 1984;  44 5624-8
• 8 Ostrem V K, Tanaka Y, Prahl J, DeLuca H F, Ikekawa N. 24- and 26-homo-1,25-dihydroxyvitamin D₃: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. Proc. Natl. Acad. Sci.  U S A.. 1987;  84 2610-4
• 9 Choi O J. Usage and constituents of medicinal plants. Seoul; lweolseogak 1991: P 621
• 10 Park H J, Kwon S H, Yoo K O, Sohn I C, Lee K T, Lee H K. Sesquiterpenes from the leaves of Ligularia fischeri var. spiciformis .  Planta Medica. 2000;  66 783-4
• 11 Lee K T, Sohn I C, Kim Y K, Choi J H, Choi J W, Park H J, Itoh Y, Miyamoto K. Tectorigenin, an isoflavone of Pueraria thunbergiana BENTH., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Biol. Pharm.  Bull.. 2001;  24 1117-21
• 12 Fesus L, Szondy Z, Uray I. Probing the molecular program of apoptosis by cancer chemopreventive agents. J. Cell Biochem.  Suppl.. 1995;  22 151-61
• 13 Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown J P, Sedivy J M, Kinzler K W, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage.  Science.. 1998;  282 1497-501
• 14 Loignon M, Fetni R, Gordon A J, Drobetsky E A. A p53-independent pathway for induction of p21^waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts.  Cancer Res.. 1997;  57 3390-4
• 15 Danova M, Giordano M, Mazzini G, Riccardi A. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk.  Res.. 1990;  14 417-22
• 16 Filmus J, Buick R N. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells.  Cancer Res.. 1985;  45 822-5
• 17 Todokoro K, Ikawa Y. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation.  Biochem Biophys Res Commun.. 1986;  135 1112-8
• 18 Baker S J, Pawlita M, Leutz A, Hoelzer D. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells.  Leukemia.. 1994;  8 1309-17
• 19 Askew D S, Ashmun R A, Simmons B C, Cleveland J L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.  Oncogene.. 1991;  6 1915-22
• 20 Shi Y, Glynn J M, Guilbert L J, Cotter T G, Bissonnette R P, Green D R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas.  Science.. 1992;  257 212-4